Page last updated: 2024-08-17

ampicillin and Tuberculosis, Multidrug-Resistant

ampicillin has been researched along with Tuberculosis, Multidrug-Resistant in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danilchanka, O; Mailaender, C; Niederweis, M1
Andrade, CH; Braga, RC; Cho, S; Franzblau, SG; Gomes, MN; Grzelak, EM; Klein, LL; Ma, R; Muratov, E; Neves, BJ; Oliveira, GR1
Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K1

Other Studies

3 other study(ies) available for ampicillin and Tuberculosis, Multidrug-Resistant

ArticleYear
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Ampicillin Resistance; ATP-Binding Cassette Transporters; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethidium; Genes, Bacterial; Humans; Membrane Transport Proteins; Models, Biological; Molecular Sequence Data; Mutagenesis, Insertional; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Transcription, Genetic; Tuberculosis, Multidrug-Resistant

2008
QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity.
    European journal of medicinal chemistry, 2017, Sep-08, Volume: 137

    Topics: Animals; Antitubercular Agents; Chalcone; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Drug Discovery; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant; Vero Cells

2017
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
    Kekkaku : [Tuberculosis], 1999, Volume: 74, Issue:5

    Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant

1999